Rett syndrome is a neurodevelopmental disorder that primarily affects girls, most of whom have mutations in the transcription regulatory gene MECP2. However, mutations in MECP2 also have been ...

Taysha Gene Therapies offers hope for Rett syndrome with innovative treatment, strong trial results, and promising regulatory ...

In March 2023, the US Food and Drug Administration approved Acadia's Daybue (trofinetide) for treating Rett syndrome in adults and paediatric patients aged two years and above. The therapy is also ...

Background Rett syndrome is a complex genetic disorder with age-specific manifestations and over ... A paediatric neurologist and a paediatrician coordinate clinical care for children up to age 18 ...

Rizzo is diagnosed with Rett syndrome, which leads to a regression of basic skills that a small child may have already learned. Her parents say that the volunteers at Sebastian Riding Associates ...

(Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for trofinetide for the treatment of Rett syndrome ...

Acadia Pharmaceuticals has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for trofinetide, aimed at treating Rett syndrome in adults and in children ...

It's not easy to deal with tragedy, but for Colin Endres and the D-Y/CCT/CCA boys hockey team, they're honoring his sister ...

2-4 A child with Rett syndrome exhibits an early period of apparently normal development until six to 18 months, when their skills seem to slow down or stagnate. This is typically followed by a ...